January 9, 2008 - ReBuilder Medical Technologies Inc. announced this week it has created a new research and development facility.
“We have leased, fitted and established the infrastructure for a new offsite engineering laboratory that will allow us to streamline the process of new product development,” said David B. Phillips, Ph.D., CEO of RBRM. “This state of the art R and D facility will house both electronic and pharmaceutical laboratories.”
“We have the ability to introduce new products into the market via the Web and support the sales of new products through our established customer service department, Daena Carter, CFO of RBRM. “We will be able to fast-track both electronic and pharmaceutical projects; each new project has the potential to double our current revenues. Our current projections give a release date for new products in the third quarter of 2008.”
For more information: www.rebuildermedical.com, www.molluscum.com.
April 28, 2026 
